NewAmsterdam Pharma

37.05
+4.04
+12.26%
NAMS
高 37.07开 33.42量 214.99万股总市值 41.73亿
低 32.36换 1.91%额 7639.36万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
NewAmsterdam Pharma(NAMS)
10-01 04:55  
$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-225170  Act: 34  Size: 205 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-18 05:25  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001341382-25-000007  Size: 6 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-11 05:45  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-114033  Size: 10 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-11 05:25  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-024111  Size: 6 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-10 00:05  
$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0001974494-25-000102  Act: 33  Size: 5 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-06 05:15  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-113276  Size: 4 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-05 05:45  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-113088  Size: 7 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-03 20:25  
$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0002004379-25-000005  Act: 33  Size: 4 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
09-02 20:35  
$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0000950170-25-112345  Act: 34  Size: 18 MB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-28 05:15  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-111738  Size: 4 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-28 05:05  
$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0002004379-25-000002  Act: 33  Size: 4 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-26 05:05  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-111241  Size: 9 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-26 05:05  
$NewAmsterdam Pharma(NAMS)$ 144 Report of proposed sale of securities Accession Number: 0002056296-25-000009  Act: 33  Size: 5 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-21 05:35  
$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001415889-25-022506  Act: 34  Size: 88 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-18 20:05  
$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0000950170-25-109567  Act: 34  Size: 255 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-16 04:15  
$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0000950170-25-109387  Act: 34  Size: 209 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-14 04:55  
$NewAmsterdam Pharma(NAMS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-021660  Size: 6 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-14 01:05  
$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001422849-25-000040  Act: 34  Size: 7 KB 网页链接
1赞
用户头像
NewAmsterdam Pharma(NAMS)
08-13 04:35  
$NewAmsterdam Pharma(NAMS)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000950170-25-107390  Act: 34  Size: 145 KB 网页链接
用户头像
NewAmsterdam Pharma(NAMS)
08-06 19:05  
$NewAmsterdam Pharma(NAMS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-103520  Act: 34  Size: 834 KB 网页链接